Circular RNAs in Breast Cancer: An Update
Biomolecules · 2024
DOI: 10.3390/biom14020158 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von Haolin Bao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Opening Project of Shaanxi Provincial Key Laboratory of Infection and Immune Diseases, Opening Project of State Key Laboratory of Oncology in South China, Key Laboratory of Human Development and Disease Research, Guangxi Medical University, Education Department of Guangxi Zhuang Autonomous Region.
Abstract (Originalsprache)
Breast cancer (BC), characterized by high heterogeneity, is the most commonly reported malignancy among females across the globe. Every year, many BC patients die owing to delayed diagnosis and treatment. Increasing researches have indicated that aberrantly expressed circular RNAs (circRNAs) are implicated in the tumorigenesis and progression of various tumors, including BC. Hence, this article provides a summary of the biogenesis and functions of circRNAs, as well as an examination of how circRNAs regulate the progression of BC. Moreover, circRNAs have aroused incremental attention as potential diagnostic and prognostic biomarkers for BC. Exosomes enriched with circRNAs can be secreted into the tumor microenvironment to mediate intercellular communication, affecting the progression of BC. Detecting the expression levels of exosomal circRNAs may provide reference for BC diagnosis and prognosis prediction. Illuminating insights into the earlier diagnosis and better treatment regimens of BC will be potentially available following elucidation of deeper regulatory mechanisms of circRNAs in this malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.
- Department of Mammary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.
- Anhui Province Key Laboratory of Cancer Translational Medicine, Bengbu Medical University, Bengbu 233030, China.
- State Key Laboratory of Oncology in South China, Cancer Center of Sun Yat-Sen University, Guangzhou 510060, China.
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China.
- Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR 999077, China.
Förderung
- Opening Project of Shaanxi Provincial Key Laboratory of Infection and Immune Diseases
- Opening Project of State Key Laboratory of Oncology in South China
- Key Laboratory of Human Development and Disease Research, Guangxi Medical University, Education Department of Guangxi Zhuang Autonomous Region
- Opening Project of Key Laboratory of Tumor Immunology and Pathology, Army Medical University, Ministry of Education
- Opening Project of Anhui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College
- Opening Project of Shanghai Key Laboratory of Molecular Imaging
- Shenzhen Science and Technology Program
- Thematic Research Support Scheme of State Key Laboratory of Liver Research, The University of Hong Kong
Zitieren
APA
Bao, H., Li, J., Zhao, Q., Yang, Q., & Xu, Y. (2024). Circular RNAs in Breast Cancer: An Update. Biomolecules. https://doi.org/10.3390/biom14020158
Vancouver
Bao H, Li J, Zhao Q, Yang Q, Xu Y. Circular RNAs in Breast Cancer: An Update. Biomolecules. 2024. doi:10.3390/biom14020158
BibTeX
@article{Bao2024,
author = {Bao, Haolin and Li, Jiehan and Zhao, Qihang and Yang, Qingling and Xu, Yi},
title = {Circular RNAs in Breast Cancer: An Update},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14020158}
}
EUVIMED